Assignee
COMPUGEN LTD
IL50 patents
Top patents by PatentIndex Score
US7569662B2Aug 4, 2009
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
COMPUGEN LTD73 citations97
US7368548B2May 6, 2008
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
COMPUGEN LTD83 citations97
US7667001B1Feb 23, 2010
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
COMPUGEN LTD75 citations96
US7745391B2Jun 29, 2010
Human thrombospondin polypeptide
COMPUGEN LTD455 citations93
US9714289B2Jul 25, 2017
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD14 citations92
US7332569B2Feb 19, 2008
Brain natriuretic peptide spliced variant
COMPUGEN LTD26 citations92
US7655781B2Feb 2, 2010
Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
COMPUGEN LTD27 citations91
US6740516B2May 25, 2004
Nucleic acid and amino acid sequences
COMPUGEN LTD21 citations87
US6625545B1Sep 23, 2003
Method and apparatus for mRNA assembly
COMPUGEN LTD34 citations84
US11623955B2Apr 11, 2023
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD3 citations83
US11220542B2Jan 11, 2022
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD3 citations83
US10751415B2Aug 25, 2020
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD6 citations83
US10227408B2Mar 12, 2019
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD6 citations83
US10213505B2Feb 26, 2019
Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD6 citations83
US10124061B2Nov 13, 2018
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD9 citations83
US7345142B2Mar 18, 2008
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
COMPUGEN LTD16 citations83
US9375466B2Jun 28, 2016
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
COMPUGEN LTD3 citations82
US9107862B2Aug 18, 2015
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
COMPUGEN LTD5 citations82
US7939634B2May 10, 2011
Polynucleotides encoding polypeptides and methods using same
COMPUGEN LTD9 citations82
US7488813B2Feb 10, 2009
Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
COMPUGEN LTD12 citations82
US9617336B2Apr 11, 2017
C10RF32 antibodies, and uses thereof for treatment of cancer
COMPUGEN LTD14 citations80
US12312404B2May 27, 2025
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD1 citations74
US11701424B2Jul 18, 2023
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD1 citations72
US10550173B2Feb 4, 2020
PVRIG polypeptides and methods of treatment
COMPUGEN LTD2 citations72
US7884180B2Feb 8, 2011
Peptides which bind to G protein-coupled receptors
COMPUGEN LTD4 citations72
US7741433B2Jun 22, 2010
Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
COMPUGEN LTD7 citations72
US7553948B2Jun 30, 2009
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
COMPUGEN LTD6 citations72
US7842459B2Nov 30, 2010
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
COMPUGEN LTD7 citations71
US6783954B2Aug 31, 2004
VEGF nucleic acid and amino acid sequences
COMPUGEN LTD7 citations71
US6506884B1Jan 14, 2003
Variant of vascular endothelial growth factor
COMPUGEN LTD6 citations71
US11225523B2Jan 18, 2022
Triple combination antibody therapies
COMPUGEN LTD3 citations68
US11795220B2Oct 24, 2023
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD0 citations62
US7714100B2May 11, 2010
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
COMPUGEN LTD3 citations62
US12558421B2Feb 24, 2026
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD0 citations61
US11795209B2Oct 24, 2023
PVRIG polypeptides and methods of treatment
COMPUGEN LTD0 citations61
US8349801B2Jan 8, 2013
Peptide ligands for G-protein coupled receptors
COMPUGEN LTD2 citations61
US7906635B2Mar 15, 2011
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
COMPUGEN LTD2 citations61
US6936450B2Aug 30, 2005
Variants of protein kinases
COMPUGEN LTD5 citations61
US10098934B2Oct 16, 2018
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
COMPUGEN LTD1 citations60
US9555087B2Jan 31, 2017
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
COMPUGEN LTD1 citations60
US7758862B2Jul 20, 2010
Hepatocyte growth factor receptor splice variants and methods of using same
COMPUGEN LTD2 citations60
US12152084B2Nov 26, 2024
Triple combination antibody therapies
COMPUGEN LTD0 citations57
US7601692B2Oct 13, 2009
MCP-1 splice variants and methods of using same
COMPUGEN LTD2 citations57
US10351625B2Jul 16, 2019
Anti-PVRIG antibodies and methods of use
COMPUGEN LTD0 citations51
US7528243B2May 5, 2009
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
COMPUGEN LTD1 citations51
US6994994B1Feb 7, 2006
Splice variants of CD40-receptor
COMPUGEN LTD3 citations51
US8987191B2Mar 24, 2015
Bioactive peptides and methods of using same
COMPUGEN LTD0 citations50
US9255132B2Feb 9, 2016
Angiopoietin derived peptides
COMPUGEN LTD0 citations49
US7678769B2Mar 16, 2010
Hepatocyte growth factor receptor splice variants and methods of using same
COMPUGEN LTD1 citations49
US9347952B2May 24, 2016
Soluble VEGFR-1 variants for diagnosis of preeclampsia
COMPUGEN LTD0 citations46